Lauren Gregory

Lauren is a European and UK Patent Attorney in the Legal 500 Tier 1 ranked CMS patent attorney practice. Lauren has particular expertise in the high profile and rapidly developing field of precision medicine, which has been repeatedly hitting the headlines with newsworthy developments moving away from ‘one size fits all’ treatments, towards therapeutics designed for a particular patient. She has cutting-edge experience helping clients push the EPO’s boundaries in the fast-developing areas of companion diagnostics, bioinformatics, immunotherapy, pharmacogenomics, personalised medicine and even medicine designed uniquely for a specific patient. Since AI technology is increasingly used for these purposes, Lauren has cross-technology experience in these areas. Her practice focuses on peptide-based technology, antisense oligonucleotides and gene therapy, antibody and antibody-conjugate technology, biomarkers, CAR-T and recombinant gene expression.

Lauren is experienced in examination and opposition proceedings at the European Patent Office (EPO), as well as the management of global patent portfolios. She also conducts due diligence for clients and advises on freedom to operate matters. Lauren is also experienced in the management of large European patent portfolios and associated strategic advice. Clients praise her tenacious attitude, attention to detail and ability to deliver creative strategies.

Lauren studied natural sciences, specialising in genetics, at the University of Cambridge, and has a PhD in developmental neurobiology from University College London.